[1]
“A comparative evaluation of myeloid-derived suppressor cells and murine double minute 2 in Iraqi breast cancer patients before therapy”, cbej, vol. 32, no. 135, pp. 46–57, Apr. 2026, doi: 10.35950/cbej.v32i135.14609.